您现在的位置是:【微信950216】银钻公司客服联系方式怎么联系 > 热点
Weight regain happens 4x faster after stopping GLP
【微信950216】银钻公司客服联系方式怎么联系2026-01-31 23:51:25【热点】9人已围观
简介Facebook TwitterThreads FlipboardCommentsPrintEmailAdd Fox News on GoogleWeigh
- Threads
- Comments
- Add Fox News on Google
Weight-loss journeys can cause social strains for GLP-1 patients, doctor says
Dr. Rocio Salas-Whalen shares how rapid GLP-1–driven weight reductions leave many individuals confronting psychological challenges that complicate relationships and social routines.
NEWYou can now listen to Fox News articles!Discontinuing the use of GLP-1 weight-loss medications triggers weight regain more than previously thought, a new study suggested.
The research, which was published in The BMJ, found that stopping the drugs is also associated with a reversal of improvements in heart and metabolic health, including cholesterol and blood pressure.
University of Oxford researchers analyzed 37 studies published up to February 2025, involving more than 9,000 participants who had undergone an average of 39 weeks of weight-loss treatment.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT LOSS DRUGS FOR 4 KEY REASONS
On average, patients regained about 0.9 pounds per month after stopping treatment. Researchers estimated that body weight and risk markers for diabetes and heart disease would return to pre-treatment levels in less than two years.

On average, patients regained about 0.9 pounds per month after stopping treatment. (iStock)
The analysis also revealed that the weight came back on nearly four times faster than after changing or quitting a diet or exercise regimen, no matter how many pounds had been shed.
OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU
"The evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long-term weight control," the researchers commented in a press release.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study authors acknowledged that only eight studies assessed treatment with newer GLP-1 drugs, at a maximum follow-up period of 12 months after the medication was stopped. This could serve as a limitation, although three additional methods of analysis provided similar results.

These findings question the effectiveness of GLP-1s for long-term weight loss, the researchers noted. (iStock)
In an editorial responding to the study, Dr. Qi Sun, associate professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, wrote that these findings "cast doubt" on the idea that GLP-1s are a "perfect cure for obesity."
CLICK HERE FOR MORE HEALTH STORIES
"People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he said. "Healthy dietary and lifestyle practices should remain the foundation for obesity treatment and management, with medications such as GLP-1 receptor agonists used as adjuncts."
"Many of the patients who quit their GLP-1 drugs could have stayed on them with the right personalized care."
很赞哦!(6)
相关文章
- 我国千兆及以上宽带接入用户达2.39亿户 占比超1/3
- 战曼联踢80分钟碰14下球0射正 哈兰德连7场无非点进球
- BBC to seek dismissal of Trump’s $10 billion lawsuit
- 中国国家画院“扎根”遵义美术馆:让艺术“驻”下来 文旅“活”起来
- 《超女》曝官方前导预告 2026年6月北美上映
- หน.พรรครักชาติ นำทีมสักการะศาลหลักเมืองสิงห์บุรี ขอให้สิ่งที่ดำเนินอยู่สำเร็จ
- 综漫:女主角落难?我趁虚而入
- 廖三宁主宰末节1周2次绝杀 胡明轩空砍18分徐杰5中0
- 只能全部重做! 《一拳超人》第三季面临崩溃边缘
- 狂野飙车9怎么更改id 狂野飙车9怎么改名字
热门文章
站长推荐
友情链接
- CBS anchor Tony Dokoupil urges accountability amid media trust crisis
- 小米有7000名法务?雷军辟谣
- 伙伴弹途不同符文效果介绍说明
- 聚力焕新 同心致远
- 振动膜生物反应器成为我国污水资源化技术“利器” ——写在国家污水资源化政策发布一周年
- 雷军:未来五年至少投2000个亿在技术研发
- 关系破裂!切尔西主帅马雷斯卡考虑辞职,未来将何去何从?
- 把持不住! 国外知名模特穿透明装战衣cos《剑星》伊芙
- 羊年正能量 《Cabal1.5》满离开启新征程
- 邱彪率队战旧主新疆:希望能够捍卫山东主场!
- “赶集”新花样!这群技工学子太会“整活”了
- 打狂犬疫苗被医院私自更换药品?贵州桐梓卫健局通报
- 智能厨余处理设备 助力厨余垃圾资源化利用
- แพทย์ในอังกฤษพบวิธีการรักษาโรคมะเร็งเม็ดเลือดขาวชนิดทีเซลล์แล้ว
- 新华社:安检“神器”“膜法”净水 手机“智”造——科技之光闪耀“一带一路”
- 2023年辽宁卷高考作文题目:材料作文
- 传奇新手任务流程与奖励详解
- 《Dogpile》PC版下载 Steam正版分流下载
- 潮汐守望者11月兑换码大全 最新2024年礼包码福利介绍
- The Ultimate Southwest US Road Trip Itinerary (Updated 2025)







